[EN] QUINAZOLIN-4-ONE DERIVATIVES<br/>[FR] DÉRIVÉS DE QUINAZOLIN-4-ONE
申请人:NOVARTIS AG
公开号:WO2014128612A1
公开(公告)日:2014-08-28
The invention relates to quinazolin-4-one compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, Formula (I) wherein R1, R2, R3, R5, R6 and L are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the class I PI3K kinases.